{"id":"https://openalex.org/W2324926893","doi":"https://doi.org/10.1097/wnf.0000000000000051","title":"Sex Differences in the Pharmacokinetics of Levodopa in Elderly Patients With Parkinson Disease","display_name":"Sex Differences in the Pharmacokinetics of Levodopa in Elderly Patients With Parkinson Disease","alternate_titles":[],"publication_year":2014,"publication_date":"2014-11-01","ids":{"openalex":"https://openalex.org/W2324926893","doi":"https://doi.org/10.1097/wnf.0000000000000051","mag":"2324926893","pmid":"https://pubmed.ncbi.nlm.nih.gov/25384078"},"language":"en","primary_location":{"id":"doi:10.1097/wnf.0000000000000051","doi":"https://doi.org/10.1097/wnf.0000000000000051","is_oa":false,"landing_page_url":"https://doi.org/10.1097/wnf.0000000000000051","pdf_url":null,"source":{"id":"https://openalex.org/S3349026","display_name":"Clinical Neuropharmacology","issn_l":"0362-5664","issn":["0362-5664","1537-162X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Neuropharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2324926893"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111494816","display_name":"Tomoaki Kumagai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I80188885","display_name":"Nippon Medical School","ror":"https://ror.org/00krab219","country_code":"JP","type":"education","lineage":["https://openalex.org/I80188885"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tomoaki Kumagai","raw_affiliation_strings":["Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan","Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan","institution_ids":["https://openalex.org/I80188885"]},{"raw_affiliation_string":"Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031367385","display_name":"Hiroshi Nagayama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I80188885","display_name":"Nippon Medical School","ror":"https://ror.org/00krab219","country_code":"JP","type":"education","lineage":["https://openalex.org/I80188885"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Hiroshi Nagayama","raw_affiliation_strings":["Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare","Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan","and reprint requests to Hiroshi Nagayama, MD, PhD, Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi Bunkyo-ku, Tokyo 113-8603, Japan; E-mail: [email\u00a0protected]","E-mail: [email\u00a0protected]","reprint requests to Hiroshi Nagayama, MD, PhD, Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi Bunkyo-ku, Tokyo 113-8603, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare","institution_ids":[]},{"raw_affiliation_string":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan","institution_ids":["https://openalex.org/I80188885"]},{"raw_affiliation_string":"and reprint requests to Hiroshi Nagayama, MD, PhD, Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi Bunkyo-ku, Tokyo 113-8603, Japan; E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I80188885"]},{"raw_affiliation_string":"E-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"reprint requests to Hiroshi Nagayama, MD, PhD, Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi Bunkyo-ku, Tokyo 113-8603, Japan","institution_ids":["https://openalex.org/I80188885"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103340433","display_name":"Tomohiro Ota","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I80188885","display_name":"Nippon Medical School","ror":"https://ror.org/00krab219","country_code":"JP","type":"education","lineage":["https://openalex.org/I80188885"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tomohiro Ota","raw_affiliation_strings":["Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare","Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare","institution_ids":[]},{"raw_affiliation_string":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan","institution_ids":["https://openalex.org/I80188885"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102009219","display_name":"Yasuhiro Nishiyama","orcid":"https://orcid.org/0000-0001-9878-5392","observed_orcids":["https://orcid.org/0000-0001-9878-5392"]},"institutions":[{"id":"https://openalex.org/I80188885","display_name":"Nippon Medical School","ror":"https://ror.org/00krab219","country_code":"JP","type":"education","lineage":["https://openalex.org/I80188885"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasuhiro Nishiyama","raw_affiliation_strings":["Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare","Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare","institution_ids":[]},{"raw_affiliation_string":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan","institution_ids":["https://openalex.org/I80188885"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048397528","display_name":"Masahiro Mishina","orcid":"https://orcid.org/0000-0002-8227-0930","observed_orcids":["https://orcid.org/0000-0002-8227-0930"]},"institutions":[{"id":"https://openalex.org/I80188885","display_name":"Nippon Medical School","ror":"https://ror.org/00krab219","country_code":"JP","type":"education","lineage":["https://openalex.org/I80188885"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Masahiro Mishina","raw_affiliation_strings":["Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare","Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare","institution_ids":[]},{"raw_affiliation_string":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan","institution_ids":["https://openalex.org/I80188885"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047854269","display_name":"Masayuki Ueda","orcid":"https://orcid.org/0000-0002-7327-8981","observed_orcids":["https://orcid.org/0000-0002-7327-8981"]},"institutions":[{"id":"https://openalex.org/I80188885","display_name":"Nippon Medical School","ror":"https://ror.org/00krab219","country_code":"JP","type":"education","lineage":["https://openalex.org/I80188885"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Masayuki Ueda","raw_affiliation_strings":["Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare","Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare","institution_ids":[]},{"raw_affiliation_string":"Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan","institution_ids":["https://openalex.org/I80188885"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5031367385"],"corresponding_institution_ids":["https://openalex.org/I80188885"],"apc_list":null,"apc_paid":null,"fwci":1.3382,"has_fulltext":false,"cited_by_count":63,"citation_normalized_percentile":{"value":0.78414222,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"37","issue":"6","first_page":"173","last_page":"176"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13252","display_name":"Sex and Gender in Healthcare","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/levodopa","display_name":"levodopa","score":0.9919999837875366},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8199999928474426},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.9879999756813049},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.8799999952316284},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9909999966621399},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.8209999799728394},{"id":"https://openalex.org/keywords/estrogen","display_name":"estrogen","score":0.9210000038146973},{"id":"https://openalex.org/keywords/carbidopa","display_name":"carbidopa","score":0.9470000267028809},{"id":"https://openalex.org/keywords/area-under-the-curve","display_name":"area under the curve","score":0.7870000004768372},{"id":"https://openalex.org/keywords/motor-complications","display_name":"motor complications","score":0.6899999976158142}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.833753228187561},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7977805733680725},{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.7674334049224854},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.7416979074478149},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5815888047218323},{"id":"https://openalex.org/C2776754145","wikidata":"https://www.wikidata.org/wiki/Q71133637","display_name":"Carbidopa","level":5,"score":0.5589808821678162},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.555143415927887},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.5490862727165222},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5132801532745361},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.5095348954200745},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.46209990978240967},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.4239838719367981},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.386410653591156},{"id":"https://openalex.org/C42407357","wikidata":"https://www.wikidata.org/wiki/Q521","display_name":"Physiology","level":1,"score":0.37213659286499023},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2239525020122528}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D012727","descriptor_name":"Sex Characteristics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/wnf.0000000000000051","doi":"https://doi.org/10.1097/wnf.0000000000000051","is_oa":false,"landing_page_url":"https://doi.org/10.1097/wnf.0000000000000051","pdf_url":null,"source":{"id":"https://openalex.org/S3349026","display_name":"Clinical Neuropharmacology","issn_l":"0362-5664","issn":["0362-5664","1537-162X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Neuropharmacology","raw_type":"journal-article"},{"id":"pmid:25384078","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25384078","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical neuropharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1924391114","https://openalex.org/W1970797730","https://openalex.org/W2002407874","https://openalex.org/W2007624784","https://openalex.org/W2017673513","https://openalex.org/W2029879331","https://openalex.org/W2034825135","https://openalex.org/W2044234384","https://openalex.org/W2053589861","https://openalex.org/W2065275335","https://openalex.org/W2069509517","https://openalex.org/W2069619217","https://openalex.org/W2072731831","https://openalex.org/W2077602429","https://openalex.org/W2086128426","https://openalex.org/W2090004947","https://openalex.org/W2094208951","https://openalex.org/W2101345641","https://openalex.org/W2132881915","https://openalex.org/W2141950943","https://openalex.org/W2156177559","https://openalex.org/W3161511225","https://openalex.org/W4210995338"],"related_works":["https://openalex.org/W2041889319","https://openalex.org/W4281677901","https://openalex.org/W3169713270","https://openalex.org/W7151313929","https://openalex.org/W4413324645","https://openalex.org/W4308046777","https://openalex.org/W2069619217","https://openalex.org/W2086128426","https://openalex.org/W3033955876","https://openalex.org/W2002407874"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Levodopa":[1],"(LD)":[2],"is":[3,211],"the":[4,11,20,48,59,65,121,125,138,143,156,159,162,172,186,189,202,215,219],"most":[5],"effective":[6],"antiparkinsonian":[7],"drug":[8],"used":[9],"in":[10,19,33,52,77,110,137,155,185,218],"treatment":[12],"of":[13,22,41,50,61,68,71,196,204,221],"Parkinson":[14],"disease":[15],"(PD).":[16],"Sex":[17],"differences":[18,32,109,217],"bioavailability":[21,195,220],"LD":[23,51,72,93,208],"have":[24,35],"been":[25,36],"shown":[26],"previously.":[27],"In":[28,43,198],"addition,":[29],"epidemiological":[30],"sex":[31,114,216],"PD":[34,56,79],"reported,":[37],"suggesting":[38],"an":[39],"involvement":[40],"estrogen.":[42,62],"this":[44],"study,":[45],"we":[46],"evaluated":[47],"pharmacokinetics":[49],"elderly":[53,83,157,187],"patients":[54,80],"with":[55,142],"to":[57,133,200,213],"examine":[58],"influence":[60],"METHODS:":[63],"After":[64],"oral":[66],"administration":[67],"a":[69,192],"tablet":[70],"100":[73],"mg/carbidopa":[74],"10":[75],"mg":[76],"128":[78],"(including":[81],"91":[82],"patients;":[84],"age":[85],"at":[86,97],"examination,":[87],"75":[88],"years":[89],"or":[90],"older),":[91],"plasma":[92],"concentrations":[94],"were":[95,106,115,131,168],"measured":[96],"6":[98],"points":[99],"until":[100],"180":[101],"minutes,":[102],"and":[103,124,149,161,178],"pharmacological":[104],"parameters":[105,112],"calculated.":[107],"Then,":[108],"these":[111],"between":[113],"compared.":[116],"RESULTS:":[117],"The":[118],"area":[119],"under":[120],"curve":[122],"(AUC)":[123],"AUC":[126,160,163],"adjusted":[127,164],"for":[128,165],"body":[129,166],"weight":[130,167],"found":[132],"be":[134],"significantly":[135,169,193],"greater":[136,170,194],"female":[139,173],"subjects":[140,145,174],"compared":[141],"male":[144],"(P":[146,175],"<":[147,151,176,180],"0.0001":[148,177],"P":[150,179],"0.0001,":[152,181],"respectively).":[153,182],"Furthermore,":[154],"patients,":[158],"among":[171],"CONCLUSIONS:":[183],"Even":[184],"cohort,":[188],"women":[190],"had":[191],"LD.":[197,222],"conclusion,":[199],"avoid":[201],"development":[203],"motor":[205],"complications":[206],"during":[207],"treatment,":[209],"it":[210],"important":[212],"consider":[214]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2324926893","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
